patent

iX Biopharma says its intellectual property rights for its sublingual wafer technology is now secured in five continents.

The patent, which is the second notice of allowance from the USPTO in recent months, is expected to expire no earlier than October 2030.

SINGAPORE (Oct 23): Specialty pharmaceutical firm iX Biopharma announced Monday that it has secured a European patent for its WaferiX drug delivery technology.

SINGAPORE (Sept 29): David Block, CEO of Sarine Technologies, says the group will take all steps necessary to stop the unlawful use of its technology as it continues to enforce its intellectual property (IP) rights.

SINGAPORE (Feb 1): The Intellectual Property of Singapore (IPOS) announced Wednesday that it is lowering the application fees for filing of patent and trademark protection from Apr 1.

SINGAPORE (Nov 21): Pharmaceutical company iX Biopharma announced that it has been granted a patent in South Africa for its WaferiX drug delivery technology. The patent will expire on Oct 26, 2030.

SINGAPORE (Oct 31): iX Biopharma announced that it has secured a Canadian patent for its WaferiX drug delivery technology.